D118 Unit 7 Study Guide

D118 Unit 7 Study Guide

Student Name

Western Governors University 

D118 Adult Primary Care for the Advanced Practice Nurse

Prof. Name

Date

D118 Unit 7 Study Guide

Differentiation of Laboratory Findings in Anemia

Anemia is a hematologic condition defined by a decrease in hemoglobin concentration, hematocrit, or circulating red blood cell (RBC) mass. Because anemia represents a manifestation rather than a diagnosis, interpretation of laboratory data is critical to identifying its underlying cause. Common etiologies include acute or chronic blood loss, bone marrow suppression or failure, malignancy-related processes, and impaired erythropoietin production associated with renal disease.

Acute blood loss, such as that resulting from trauma, gastrointestinal hemorrhage, or hemolysis, may initially present with normal mean corpuscular volume (MCV) and indices. Over time, hemoglobin and hematocrit decline as intravascular volume equilibrates. A compensatory increase in reticulocyte count typically occurs within several days, reflecting an intact bone marrow response.

Chronic blood loss most commonly leads to iron deficiency anemia. This pattern is frequently associated with occult gastrointestinal bleeding or prolonged gynecologic blood loss. Laboratory findings demonstrate depleted iron stores, evidenced by low ferritin levels, reduced serum iron, elevated total iron-binding capacity (TIBC), and microcytic, hypochromic RBCs.

Bone marrow disorders, including aplastic anemia and myelodysplastic syndromes, impair hematopoiesis at the source. These conditions often produce pancytopenia with inappropriately low reticulocyte counts and abnormal bone marrow cellularity. In contrast, anemia associated with malignancy may arise from chronic inflammation, marrow infiltration, or cytotoxic therapy and is commonly normocytic with elevated inflammatory markers.

Renal-related anemia occurs secondary to reduced erythropoietin synthesis. This results in decreased RBC production and manifests as normocytic, normochromic anemia, often worsening as chronic kidney disease progresses.

What Are the Key Laboratory Patterns in Common Types of Anemia?

The following table summarizes distinguishing laboratory features that aid in differentiating common anemia etiologies:

Etiology	MCV	Reticulocyte Count	Ferritin	Additional Findings
Acute blood loss	Normal	Elevated	Normal	Declining hemoglobin and hematocrit
Chronic blood loss (iron deficiency)	Low	Low or normal	Low	Increased TIBC
Bone marrow failure	Normal or high	Low	Normal	Pancytopenia
Malignancy-associated anemia	Normal	Low	Normal or high	Elevated CRP or ESR
Renal failure	Normal	Low	Normal	Decreased erythropoietin

---

What Laboratory Values in Metabolic Syndrome Require Nephrology Referral and Why?

In patients with metabolic syndrome, early identification of renal involvement is essential to prevent irreversible kidney damage. Referral to nephrology is recommended when the estimated glomerular filtration rate (eGFR) declines below 30 mL/min/1.73 m² or when urinary albumin excretion exceeds 300 mg/g creatinine.

An eGFR at this level corresponds to stage 4 chronic kidney disease, a point at which specialized management is required to slow disease progression and plan for renal replacement therapy. Significant albuminuria reflects glomerular injury and is independently associated with increased cardiovascular morbidity and mortality, underscoring the need for early specialist intervention (National Kidney Foundation, 2023).

---

What Is the First-Line Treatment for Generalized Anxiety Disorder?

The preferred first-line pharmacologic treatment for generalized anxiety disorder (GAD) consists of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs). Agents such as sertraline and escitalopram (SSRIs), along with venlafaxine and duloxetine (SNRIs), have demonstrated robust efficacy in reducing anxiety symptoms.

These medications are favored due to their favorable side effect profiles, safety with long-term use, and effectiveness in addressing both psychological and somatic symptoms of anxiety. Cognitive behavioral therapy (CBT) is strongly recommended as a complementary intervention, as combined pharmacologic and psychotherapeutic treatment yields superior outcomes.

---

Differentiation of the Types of Urinary Incontinence

Urinary incontinence encompasses several distinct clinical subtypes, each resulting from different underlying mechanisms. Accurate classification is essential, as management strategies vary significantly.

Type	Description
Stress incontinence	Involuntary leakage during activities that increase intra-abdominal pressure, such as coughing or lifting
Urge incontinence	Sudden, overwhelming urge to void followed by involuntary urine loss
Mixed incontinence	Combination of stress and urge features
Overflow incontinence	Continuous or intermittent leakage due to incomplete bladder emptying

---

In Which Patients Should Oxybutynin Be Avoided?

Oxybutynin, an anticholinergic agent used to treat overactive bladder, is contraindicated in several patient populations due to its antimuscarinic effects. Patients with myasthenia gravis should avoid oxybutynin because it may exacerbate neuromuscular weakness. It is also contraindicated in individuals with untreated narrow-angle glaucoma, urinary retention caused by benign prostatic hyperplasia, and inflammatory bowel diseases such as ulcerative colitis or Crohn’s disease, where reduced gastrointestinal motility may worsen symptoms.

---

What Medications Are Appropriate for the Treatment of Graves Disease and Why?

Graves disease is an autoimmune disorder characterized by excessive thyroid hormone production due to thyroid-stimulating immunoglobulins. In the United States, radioactive iodine ablation is the most commonly used definitive treatment, as it selectively destroys hyperfunctioning thyroid tissue and provides long-term disease control.

Antithyroid medications such as methimazole are frequently used for initial management, in preparation for radioactive iodine therapy, or in patients for whom ablation is contraindicated. Beta-adrenergic blockers are routinely prescribed as adjunct therapy to control adrenergic symptoms including palpitations, tremors, and anxiety.

---

Common Clinical Manifestations of Addison’s Disease

Addison’s disease, also known as primary adrenal insufficiency, results from inadequate production of cortisol and aldosterone. Patients typically present with nonspecific but progressive symptoms such as chronic fatigue, weight loss, hypotension, hyperpigmentation, and electrolyte abnormalities including hyponatremia and hyperkalemia.

During periods of physiological stress, patients are at risk for adrenal crisis, a medical emergency characterized by severe hypotension, vomiting, dehydration, and shock. Immediate administration of intravenous glucocorticoids and fluid resuscitation is critical for survival.

---

Educational Plan for a Patient With Type 2 Diabetes

Successful management of type 2 diabetes relies heavily on patient education. Core components include lifestyle modification, medication adherence, blood glucose monitoring, and prevention of acute and chronic complications. Regular physical activity improves insulin sensitivity and enhances glucose uptake by skeletal muscle, with effects lasting up to 48 hours. As a result, medication dosages may require adjustment to prevent hypoglycemia.

Nutritional counseling should emphasize portion control, balanced macronutrient intake, and gradual weight loss. Patients must also be educated on recognizing hypoglycemia, implementing sick-day management strategies, and maintaining consistent follow-up. Exercise plays a critical preventive role by delaying progression from prediabetes to overt diabetes.

---

Which Laboratory Test Is Most Important for Monitoring Kidney Function in Diabetes?

Microalbuminuria is the earliest and most sensitive marker for diabetic kidney disease. Urinary albumin excretion greater than 30 mg per 24 hours indicates early nephropathy and precedes overt declines in renal function.

Assessment methods include the albumin-to-creatinine ratio from a random urine sample, timed urine collections, or 24-hour urine testing. Diagnosis requires confirmation with at least two abnormal results over a 3–6 month period. Regular monitoring allows for timely intervention and evaluation of therapeutic efficacy.

---

What Is the Clinical Significance of the Philadelphia Chromosome?

The Philadelphia chromosome is a hallmark genetic abnormality in chronic myelogenous leukemia (CML). It results from a reciprocal translocation between chromosomes 9 and 22, producing the BCR-ABL fusion gene. This gene encodes a constitutively active tyrosine kinase that drives unchecked leukocyte proliferation.

The discovery of the Philadelphia chromosome revolutionized cancer biology and enabled the development of targeted therapies such as tyrosine kinase inhibitors, dramatically improving survival and transforming CML into a manageable chronic condition.

---

Clinical Practice Guidelines for Type 1 and Type 2 Diabetes

Differentiating between type 1 and type 2 diabetes is essential for appropriate management. Type 1 diabetes requires lifelong insulin therapy due to absolute insulin deficiency. Type 2 diabetes treatment includes lifestyle modification, oral antidiabetic agents, and insulin when necessary.

During pregnancy, insulin remains the standard of care; however, oral agents such as metformin and glyburide are increasingly recognized as safe and effective in select patients. Measurement of C-peptide levels can assist in distinguishing diabetes type when clinical presentation is unclear.

---

Diagnosis, Laboratory Findings, and Treatment of Hypothyroidism

Hypothyroidism is diagnosed through laboratory testing demonstrating elevated thyroid-stimulating hormone (TSH) levels accompanied by low free thyroxine (T4). Management involves lifelong thyroid hormone replacement to normalize metabolic function and suppress excess TSH secretion.

In patients with thyroid cancer, TSH suppression goals are individualized based on recurrence risk. Intermediate- and high-risk patients require TSH levels below 0.3 mIU/L, while low-risk patients maintain levels between 0.3 and 2.0 mIU/L.

---

Medications Used in the Treatment of Depression

Depression is treated using several classes of antidepressants, selected based on symptom profile, comorbidities, and tolerability.

Class	Example	Typical Dose Range
SSRI	Sertraline	50–200 mg/day
SNRI	Venlafaxine	75–225 mg/day
Atypical	Bupropion	150–300 mg/day
TCA	Amitriptyline	25–150 mg/day
MAOI	Phenelzine	45–90 mg/day

SSRIs and SNRIs are considered first-line agents due to their efficacy, safety, and lower risk of serious adverse effects.

---

Which Anemia Presents With a Beefy Red Tongue?

Vitamin B12 deficiency anemia, a form of megaloblastic anemia, is characteristically associated with a smooth, beefy red tongue, known as glossitis. Neurologic manifestations such as peripheral neuropathy, gait disturbances, and cognitive changes may also occur. Early identification and treatment are essential, as prolonged deficiency can result in irreversible neurological damage.

---

References

American Diabetes Association. (2024). Standards of medical care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S1–S350.

Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill.

Katzung, B. G., & Trevor, A. J. (2023). Basic and clinical pharmacology (15th ed.). McGraw-Hill.

Melmed, S., Polonsky, K. S., Larsen, P. R., & Kronenberg, H. M. (2020). Williams textbook of endocrinology (14th ed.). Elsevier.

National Kidney Foundation. (2023). KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements.

World Health Organization. (2022). Nutritional anaemias: Tools for effective prevention and control. WHO Press.